Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Agammaglobulinemia × SARS-CoV-2 inactivated vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1 Influenza, Human 1 Hematologic Diseases 1 Agammaglobulinemia 1

Interventions

SARS-CoV-2 inactivated vaccines 1 Lenalidomide 1 Influenza Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Terminated

3 enrolled 7 charts

LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡